1. Home
  2. DCTH vs BLZE Comparison

DCTH vs BLZE Comparison

Compare DCTH & BLZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • BLZE
  • Stock Information
  • Founded
  • DCTH 1988
  • BLZE 2007
  • Country
  • DCTH United States
  • BLZE United States
  • Employees
  • DCTH N/A
  • BLZE 346
  • Industry
  • DCTH Medical/Dental Instruments
  • BLZE Computer Software: Prepackaged Software
  • Sector
  • DCTH Health Care
  • BLZE Technology
  • Exchange
  • DCTH Nasdaq
  • BLZE Nasdaq
  • Market Cap
  • DCTH 388.3M
  • BLZE 533.6M
  • IPO Year
  • DCTH N/A
  • BLZE 2021
  • Fundamental
  • Price
  • DCTH $10.71
  • BLZE $9.80
  • Analyst Decision
  • DCTH Strong Buy
  • BLZE Strong Buy
  • Analyst Count
  • DCTH 4
  • BLZE 7
  • Target Price
  • DCTH $24.50
  • BLZE $10.21
  • AVG Volume (30 Days)
  • DCTH 500.7K
  • BLZE 765.4K
  • Earning Date
  • DCTH 11-07-2025
  • BLZE 11-06-2025
  • Dividend Yield
  • DCTH N/A
  • BLZE N/A
  • EPS Growth
  • DCTH N/A
  • BLZE N/A
  • EPS
  • DCTH 0.06
  • BLZE N/A
  • Revenue
  • DCTH $70,240,000.00
  • BLZE $137,286,000.00
  • Revenue This Year
  • DCTH $159.22
  • BLZE $16.78
  • Revenue Next Year
  • DCTH $41.22
  • BLZE $13.98
  • P/E Ratio
  • DCTH $193.75
  • BLZE N/A
  • Revenue Growth
  • DCTH 491.35
  • BLZE 19.08
  • 52 Week Low
  • DCTH $8.08
  • BLZE $3.94
  • 52 Week High
  • DCTH $18.23
  • BLZE $9.92
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 43.43
  • BLZE 77.40
  • Support Level
  • DCTH $10.60
  • BLZE $9.27
  • Resistance Level
  • DCTH $11.38
  • BLZE $9.92
  • Average True Range (ATR)
  • DCTH 0.44
  • BLZE 0.42
  • MACD
  • DCTH 0.01
  • BLZE 0.05
  • Stochastic Oscillator
  • DCTH 6.02
  • BLZE 94.12

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About BLZE Backblaze Inc.

Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage, which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and Other regions.

Share on Social Networks: